Blogs

Jul 13, 2017
Applied Clinical Trials
This Q&A discusses how the movement in making studies more patient-centric continues, and Pfizer is now implementing its own mHealth study in Lupus.
Jul 06, 2017
Applied Clinical Trials
Peter O'Donnell discusses the interest expressed by members states to host the EMA.
Jul 05, 2017
Applied Clinical Trials
Peter O’Donnell discusses the argument on whether or not European researchers should be allowed to continue using non-human primates in their research.
Jul 05, 2017
Applied Clinical Trials
In this article, we will analyze themes from asthma patient conversations via HealthUnlocked, an online healthcare social network, and compare these themes to asthma clinical trial endpoints from large pharma studies.
Jul 05, 2017
Applied Clinical Trials
The FDA ruling that exempts biosimilar makers from waiting an extra six months after approval to distribute a new product should help overcome delays in future biosimilar sales, writes Jill Wechsler.
Jun 30, 2017
Applied Clinical Trials
Peter O'Donnell discusses Estonia taking over the rotating presidency of the Council of the European Union.
Jun 30, 2017
Applied Clinical Trials
Rob DiCicco, VP of Clinical Innovation and Digital Platforms at GSK, will discuss the TransCelerate protocol template initiative in this interview.
Jun 20, 2017
Applied Clinical Trials
Tanya Bridges and Donna Benson, from two non-affiliated study sites, discuss the burdens of using paper source forms, and their impact on resources and trial execution at study sites.
Jun 15, 2017
Applied Clinical Trials
4G Clinical head of marketing, Amy Ripston interviews Catherine Hall, director of operational excellence, at Sunovion to discuss how IRT bridges the gap between clinical and supply, and how interactive response technologies (IRT) can be leveraged to enable innovative trial designs.
Jun 13, 2017
Applied Clinical Trials
We interviewed Pfizer exec, Dr. Jonathan Rowe, about how they are leveraging predictive models to manage study risk and quality.
native1_300x100
lorem ipsum